Press Release
Category Added in a WPeMatico Campaign
-
Cision PR Newswire10 March 2026
Samsung Biologics Announces Collaboration with Lilly to Establish New Gateway Labs Site in Korea
Partnership expands Lilly’s global network of shared innovation hubs and strengthens Samsung Biologics’ role as a connector between early-stage innovation…
Read More » -
Cision PR Newswire10 March 2026
Full Sail Partners Announces New Leadership Structure to Support Continued Growth
Five Directors named to guide consulting, training, technology, and automation services for clients nationwide STEAMBOAT SPRINGS, Colo., March 10, 2026…
Read More » -
Cision PR Newswire10 March 2026
ATDev Advances Robotic Mobility as SXSW Pitch 2026 Finalist
ATDev has been invited to pitch in the Healthcare, AssistiveTech & BioTech category PITTSBURGH, March 10, 2026 /PRNewswire/ — Assistive…
Read More » -
Cision PR Newswire10 March 2026
Kingsoft Cloud to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 25, 2025
BEIJING, March 9, 2026 /PRNewswire/ — Kingsoft Cloud Holdings Limited (NASDAQ: KC and HKEX: 3896) (“Kingsoft Cloud” or the “Company”),…
Read More » -
Cision PR Newswire10 March 2026
Dingdong (Cayman) Limited to Hold 2026 Annual General Meeting of Shareholders on March 27, 2026
SHANGHAI, March 10, 2026 /PRNewswire/ — Dingdong (Cayman) Limited (the “Company“) (NYSE: DDL), a leading fresh grocery e-commerce company in…
Read More » -
Cision PR Newswire10 March 2026
Canadian Tech Company Launches the “Trivago of Groceries”
Using AI for the Good of the Consumer. NORTH BAY, ON, March 10, 2026 /CNW/ – As grocery prices continue…
Read More » -
Cision PR Newswire10 March 2026
Novella names Antonio Martinez Descalzo as CEO to Lead Expansion
New CEO to drive global commercialization of precision botanical ingredients for the nutraceutical industry MODI’IN, Israel, March 10, 2026 /PRNewswire/…
Read More » -
Cision PR Newswire10 March 2026
Genprex to Participate at BIO Europe Spring 2026
AUSTIN, Texas, March 10, 2026 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company…
Read More » -
Cision PR Newswire10 March 2026
Edgewise Announces Positive Long-Term Sevasemten Data Demonstrating Sustained Functional Stabilization in Becker Muscular Dystrophy Through 3.5 Years of Follow-Up
–The MESA data show stabilization of function in participants on sevasemten versus the predicted functional decline observed in Becker natural…
Read More » -
Cision PR Newswire10 March 2026
Eight Leading Midwestern Universities Launch Third Coast Foundry, a New Bay Area Base for Innovation and Venture Collaboration
Together, the partner universities account for nearly $10 billion in annual research investment and educate more than 300,000 students, producing…
Read More »





